Section 25-1.5-115.3 - Non-laboratory synthetic opioid detection tests - appropriation - definitions - repeal(1)For the 2022-23 state fiscal year, the general assembly shall appropriate six hundred thousand dollars to the department for the purpose of purchasing non-laboratory synthetic opioid detection tests and other drug testing equipment. Any unexpended money remaining at the end of the 2022-23 state fiscal year from this appropriation: (a) Does not revert to the general fund or any other fund;(b) May be used by the department in the 2023-24 and 2024-25 state fiscal years without further appropriation; and(c) Must not be used for any other purpose other than the purpose set forth in this section.(2) The department shall distribute the non-laboratory synthetic opiate detection tests to eligible entities. The department may prioritize the distribution of non-laboratory synthetic opiate detection tests to eligible entities based on the need of each entity and the availability of the non-laboratory synthetic opiate detection tests as determined by the department.(3) As used in this section, unless the context otherwise requires: (a) "Eligible entity" means a person or entity described in section 12-30-110 (1)(a); except that an employee or agent of a school must be acting in accordance with section 12-30-110 (1)(b), (2)(b), or (4)(b), and, as applicable, section 22-1-119.2.(b) "Non-laboratory synthetic opiate detection test" means a product that is intended or designed to detect the presence of a synthetic opiate.(4) This section is repealed, effective July 1, 2025.Amended by 2024 Ch. 458,§ 6, eff. 6/6/2024.Added by 2022 Ch. 225, § 22, eff. 7/1/2022.